AbbVie
Business & Industry
- GSK completes acquisition of IDRx, Inc.
- FDA approves Roche's Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
- AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson's disease investigational gene therapy
- One of the largest global surveys of society's attitudes toward breakthrough technologies
- Bayer acquires HiDoc Technologies and Cara Care® app for irritable bowel syndrome
Research & Development
- NHS urged to offer single pill to all over-50s to prevent heart attacks and strokes
- Naturally occurring molecule rivals Ozempic in weight loss, sidesteps side effects
- Future drugs may snap supply chain fueling breast cancer
- Researchers reveal key mechanism behind bacterial cancer therapy
- Common malaria drug repurposed to fight cancer
- Switching between defense and attack - immune cells with dual role
- Designing self-destructing bacteria to make effective tuberculosis vaccines
Conferences & Events
- New insights into T and B cells offer hope for autoimmune disease sufferers
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
Regulatory Affairs
- FDA approves first gene therapy for treatment of aromatic L-amino acid decarboxylase deficiency
- FDA approves new treatment for hemophilia A or B
- FDA approves nasal spray influenza vaccine for self- or caregiver-administration
- FDA approves first nasal spray for treatment of anaphylaxis
- FDA approves nonsteroidal treatment for Duchenne muscular dystrophy